Menu

Work spaces lock

Image

MIT linQ

Catalyst

IDEA²

IMPACT

Rising Stars

MIT

  • MIT linQ announces 2026 class of IDEA²

    Eight international teams developing new biomedical technologies for range of medical challenges CAMBRIDGE, MASSACHUSETTS, 1 DECEMBER 2025—MIT linQ, an international biomedical technology innovation consortium based in the Massachusetts Institute of Technology Institute for Medical Engineering and Sciences (MIT IMES), introduced the eight teams admitted to IDEA2 2026. The seven-month program provides intensive innovation method training, collaborative… Read More

  • MIT linQ announces 2025 class of IDEA²

    Nine international teams developing new biomedical technologies for range of medical challenges CAMBRIDGE, MASSACHUSETTS, 12 NOVEMBER 2024—MIT linQ, an international biomedical technology innovation consortium based in the Massachusetts Institute of Technology Institute for Medical Engineering and Sciences (MIT IMES), introduced the nine teams admitted to IDEA2 2025. The seven-month program provides intensive innovation method training, collaborative… Read More

  • MIT linQ concludes IDEA² 2024 edition

    Nine international teams developed technology innovations for maternal health, cancer therapy, vaccine design, bone regeneration, and more CAMBRIDGE, MASSACHUSETTS, 8 July 2024—MIT linQ, a health technology innovation initiative at the Massachusetts Institute of Technology, graduated the nine teams of IDEA2 2024. IDEA2 is an international mentorship program that helps emerging healthtech innovators to drive their new technology… Read More

  • MIT linQ announces 2024 class of IDEA²

    Nine international teams developing new biomedical technologies for range of medical challenges CAMBRIDGE, MASSACHUSETTS, 9 NOVEMBER 2023—MIT linQ, an international biomedical technology innovation consortium based in the Massachusetts Institute of Technology Institute for Medical Engineering and Sciences (MIT IMES), introduced the eight teams admitted to IDEA2 2024. The seven-month program provides intensive innovation method training, collaborative… Read More

  • MIT linQ concludes IDEA² 2022 edition

    Eight international teams developed technology innovations for patient safety, vaccine manufacturing, neurological disorders, and more CAMBRIDGE, MASSACHUSETTS, 23 December 2022—MIT linQ, a health technology innovation initiative at the Massachusetts Institute of Technology, graduated the eight teams of IDEA2 2022. IDEA2 is an international mentorship program that helps emerging healthtech innovators to drive their new technology ideas toward… Read More

  • MIT linQ announces 2022 class of IDEA²

    8 international teams developing new biomedical technologies for range of medical challenges CAMBRIDGE, MASSACHUSETTS, 6 JUNE 2022—MIT linQ, an international biomedical technology innovation consortium based in the Massachusetts Institute of Technology Institute for Medical Engineering and Sciences (MIT IMES), introduced the eight teams admitted to IDEA2 2022. The seven-month program provides intensive innovation method training, collaborative project… Read More

  • MIT linQ concludes IDEA² 2021 edition

    10 international teams developed technology innovations for women’s health, major surgery, pandemic response, and more CAMBRIDGE, MASSACHUSETTS, 15 December 2021—MIT linQ, a health technology innovation initiative at the Massachusetts Institute of Technology, graduated the 10 teams of IDEA2 2021. IDEA2 is an international mentorship program that helps emerging healthtech innovators to drive their new technology ideas toward… Read More

  • MIT linQ announces 2021 class of IDEA²

    11 international teams developing new biomedical technologies CAMBRIDGE, MASSACHUSETTS, 14 JUNE 2021—MIT linQ, an international biomedical technology innovation consortium based in the Massachusetts Institute of Technology Institute for Medical Engineering and Sciences (MIT IMES), introduced the 11 teams admitted to IDEA2 2021. The seven-month program provides intensive innovation method training, collaborative project development, team-specific mentoring, and expertise… Read More

  • MIT linQ concludes IDEA² Global 2019 edition

    12 teams developed diverse new healthcare technologies for depression, colon cancer, asthma, and other diseases and health risks CAMBRIDGE, MASSACHUSETTS—MIT linQ, a health technology innovation initiative at the Massachusetts Institute of Technology, recognized the 12 teams of 2019 IDEA2 Global, a six-month program to help biomedical innovators develop their ideas and identify strategies to realize them.… Read More

  • MIT linQ Announces 2019 Class of IDEA² Global

    14 international teams developing new biomedical technologies CAMBRIDGE, MASSACHUSETTS, 30 MAY 2019 – MIT linQ, an international biomedical technology innovation consortium based in the Institute for Medical Engineering & Sciences (IMES) at MIT, introduced the 14 teams admitted to IDEA² Global 2019. The seven-month program provides intensive innovation method training, collaborative project development, team-specific mentoring,… Read More